# Endothelin-1 and Cardiac Allograft Vasculopathy (CAV)

> **NCT05373108** · PHASE4 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 19 (actual)

## Conditions studied

- Cardiac Allograft Vasculopathy

## Interventions

- **DRUG:** Macitentan

## Key facts

- **NCT ID:** NCT05373108
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-19
- **Primary completion:** 2023-02-14
- **Final completion:** 2023-02-14
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2024-03-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05373108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05373108, "Endothelin-1 and Cardiac Allograft Vasculopathy (CAV)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05373108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*